Observing treatment effects in patients with AL-CM
Clinical Study Protocol for the Treatment of Immunoglobulin Light Chain Amyloidosis Cardiomyopathy
This study is looking at how well current treatments work for people with AL-CM by following their experiences over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT04924998 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients diagnosed with Immunoglobulin Light Amyloidosis Cardiomyopathy (AL-CM) to monitor the effects of current treatments and conduct long-term follow-up. Participants aged 18 to 90 years will be recruited from the Second Affiliated Hospital of Zhejiang University School of Medicine. The study aims to gather data on treatment outcomes and patient experiences over time. By observing these patients, researchers hope to gain insights into the effectiveness of existing therapies for AL-CM.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-90 diagnosed with AL-CM who can understand and cooperate with the study requirements.
Not a fit: Patients who are unable to understand the study or unwilling to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of treatment effectiveness for patients with AL-CM, potentially leading to improved management strategies.
How similar studies have performed: While this approach is observational, similar studies in the past have provided valuable insights into treatment effects for other conditions, suggesting potential for meaningful findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18-90 years, regardless of gender, diagnosed with Al-CM at the Second Affiliated Hospital of Zhejiang University School of Medicine; * Patients have the ability to understand the test, can cooperate with investigators. Exclusion Criteria: * Unable to understand or unwilling to fill in informed consent forms or follow visitors
Where this trial is running
Hangzhou, Zhejiang
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China — Hangzhou, Zhejiang, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.